These findings are in line with prior studies conducted on non-pediatric cancers showing the overexpression of TWIST1 in high grade and invasive/aggressive breast, bladder, cervical, ovarian, and hepatocellular cancers where it might also serve as prognostic factor for poor outcome31. Here, TWIST1 is linked to hepatocellular carcinoma.